Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/hplc-method-development-for-pharmaceuticals/ahuja/descriptif_3572128
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3572128

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

HPLC Method Development for Pharmaceuticals Separation Science and Technology Series

Langue : Anglais

Coordonnateurs : Ahuja Satinder, Rasmussen Henrik

Couverture de l’ouvrage HPLC Method Development for Pharmaceuticals

High pressure, or high performance, liquid chromatography (HPLC) is the method of choice for checking purity of new drug candidates, monitoring changes during scale up or revision of synthetic procedures, evaluating new formulations, and running control/assurance of the final drug product. HPLC Method Development for Pharmaceuticals provides an extensive overview of modern HPLC method development that addresses these unique concerns. Includes a review and update of the current state of the art and science of HPLC, including theory, modes of HPLC, column chemistry, retention mechanisms, chiral separations, modern instrumentation (including ultrahigh-pressure systems), and sample preparation. Emphasis has been placed on implementation in a pharmaceutical setting and on providing a practical perspective.

HPLC Method Development for Pharmaceuticals is intended to be particularly useful for both novice and experienced HPLC method development chemists in the pharmaceutical industry and for managers who are seeking to update their knowledge.

1. Overview (Satinder Ahuja).
2. HPLC Theory (Y.V. Kazakevich).
3. HPLC Columns and Packings (U.D. Neue et al.).
4. Column Characterization and Selection (D. Visky).
5. Chiral Separations (Xiande Wang et al.).
6. Contemporary Liquid Chromatographic Systems for Method Development (M. Swartz).
7. Hyphenated Techniques (D.L. Norwood et al.).
8. HPLC Sample Preparation (G. Slack, N.H. Snow).
9. Instrument and Software Qualification and Validation (D. Van Geel).
10. Pharmaceutical Development: From Pre-clinical to Post Approval (K. Bynum).
11. HPLC Method Development for Drug Discovery LC-MS Assays in Rapid PK Applications (Xiaoying Xu, W. Korfmacher).
12. HPLC Method Development in Early Phase Pharmaceutical Development (H.T. Rasmussen et al.).
13. HPLC Method Development in Late Phase Pharmaceutical Development (M. Ilias Jimidar).
14. Use of HPLC for In-process Testing (C. Richardson).
15. Method Development for Biomolecules (D.E. Raynie, J.L. Driver).
16. Method Validation (M. Ilias Jimidar et al.).
17. Troubleshooting HPLC Methods (H. McNair).
18. Molecularly Imprinted Polymers as Sorbents for Separations and Extractions (M.T. Koesdjojo et al.).
For researchers, analysts, managers, and regulators of the pharmaceutical industry
Satinder Ahuja is a leading expert on water quality improvement. He earned his PhD in analytical chemistry from the University of the Sciences in Philadelphia. He worked for Novartis Corp. in various leadership positions for over 25 years and taught as an adjunct professor at Pace University for over 10 years. As president of Ahuja Consulting, he advises on water quality issues relating to chemicals and pharmaceuticals. A member of the executive committee of the Rivers of the World Foundation (ROW), Dr. Ahuja has organized numerous global symposia on improving water quality, including presentations for the American Chemical Society and UNESCO. Dr. Ahuja has published numerous papers and more than 25 books. His latest books are Contaminants in Our Water (ACS, 2020); Evaluating Water Quality to Prevent Future Disasters (Elsevier, 2019); Advances in Water Purification Techniques (Elsevier, 2019); and Chemistry and Water (Elsevier, 2017).
  • Covers the requirements for HPLC in a pharmaceutical setting including strategies for software and hardware validation to allow for use in a regulated laboratory
  • Provides an overview of the pharmaceutical development process (clinical phases, chemical and pharmaceutical development activities)
  • Discusses how HPLC is used in each phase of pharmaceutical development and how methods are developed to support activities in each phase

Date de parution :

Ouvrage de 532 p.

Sous réserve de disponibilité chez l'éditeur.

280,40 €

Ajouter au panier

Thèmes de HPLC Method Development for Pharmaceuticals :